Sau May Wong1, Jacobus F.A. Jansen1, C. Eleana Zhang2, Julie Staals2, Paul A.M. Hofman1, Joachim E. Wildberger1, Robert J. van Oostenbrugge2, Cécile R.L.P.N. Jeukens1, and Walter H. Backes1
1Radiology & Nuclear Medicine, Maastricht University Medical Centre, Maastricht, Netherlands, 2Neurology, Maastricht University Medical Centre, Maastricht, Netherlands
Synopsis
Measuring subtle leakage through the
blood-brain barrier using DCE-MRI is challenging since their magnitude is lower
than in high-grade tumors. To have a clinical application, this method has to
be reproducible. The reproducibility of the transfer constant (Ki)
and fractional plasma volume (vp) using dual temporal
resolution DCE-MRI was investigated in 14 patients with cerebrovascular
disease. Low CVs and moderate to high ICCs demonstrate that despite
the noisy nature of the measurement, the method is moderately reproducible.
Still, cautious interpretation of the Ki and vp in individual patients is needed. Day-to-day
variations may be partly compensated by using session-averaged VIFs.Introduction
DCE-MRI is
widely used in the clinic to determine leakage of a contrast medium in tumors.
Recently, this method is increasingly applied to estimate the rather subtle
leakage through the blood-brain barrier (BBB) in cerebrovascular and
neurodegenerative pathology (e.g. cerebral small vessel disease (cSVD) and
Alzheimer’s disease)1,2. Several studies have shown that
breakdown of the BBB might play a pivotal role in the pathophysiology of these
diseases3,4.
Measuring subtle leakage is challenging as
the magnitude is several orders lower than that found in high-grade tumors. To have
a clinical application, the measurement of subtle leakage using DCE-MRI has to be
reproducible. The aim is to determine the reproducibility of the pharmacokinetic
measures, the transfer constant (Ki)
and fractional plasma volume (vp),
using dual temporal resolution DCE-MRI in patients with cerebrovascular disease.
In addition, the effect of different vascular input functions (VIFs) on the
reproducibility was investigated.
Methods
Patients: MR imaging was conducted twice in 14
patients with cSVD (n=10), cortical stroke (n=3) or intracerebral hemorrhage
(n=1) (age 68.0±6.8y) to obtain a range of leakage values. Imaging was
conducted on a 3.0 Tesla MR scanner (Philips Achieva TX) on two separate days with
on average 2.1±2.3 days in between.
Data
acquisition: Dual
temporal resolution DCE-MRI was used for dynamic imaging to quantify
the leakage rate through the BBB and the
microvascular blood plasma space5. The acquisition compromises
the combination of two dynamic sequences with different dynamic scan times (DST).
The first sequence was
applied during bolus injection (DST 3.2 s, TR/TE = 5.6/2.5 ms, FOV: 256x200x50
mm3, voxel size 2x2x5 mm3, 29 volumes). Subsequently, the
second sequence was conducted (DST 30.5 s, TR/TE = 5.6/2.5 ms, FOV: 256x256x100
mm3, voxel size 1x1x2 mm3, 45 volumes). The contrast
agent (Gadobutrol, dose 0.1 mmol/kg, 3 ml/s) was injected in the antecubital
vein.
Data analysis: Voxel wise calculation of Ki and vp
was performed by using
the Patlak graphical approach6. Histogram analysis was performed to
calculate the mean vp and the 75th percentile of
Ki,
to determine the
strongest leakage region with respect to noise. The following regions of interest (ROIs) were analyzed: vascular
lesion (VL), white matter (WM) and grey matter (GM) (both distant from the VL).
The individual VIFs were
taken from the sagittal sinus. To explore the influence of the VIF on the
day-to-day variation, a session-averaged VIF per subject was also calculated over
the two sessions.
Reproducibility
was expressed by 2 measures: (i) the
correlation coefficient (CV) to measure the relative within-subject variation
and (ii) the intraclass correlation coefficient (ICC) that expresses the part
of the total variance ascribed to biological variation rather than measurement
error. Lower CV and higher ICC are indicative of good reproducibility. Bland-Altman
plots and the 95% limits of agreement (LoA) were also depicted7.
Results
No correlation between the magnitude and
difference between sessions was present for the Ki and vp
in the WM and GM
(Fig. 1,2).
Table
1 shows the reproducibility values. Fairly low CVs and high ICCs were found in
the WM and GM for both measures. For the VLs, high ICC was observed for Ki, whereas for vp it was low (Fig. 3).
Using
session-averaged VIFs instead of individual VIFs, higher CVs and lower ICCs
were observed for Ki. In
contrast, lower CVs and higher ICCs were seen for the vp .
Discussion and conclusion
The magnitude of Ki and vp are comparable to the inter-session variability (LoA) (Fig. 1,2).
Moreover, low CVs and moderate to high ICCs observed for Ki and vp
indicate a
moderate reproducibility in the WM and GM. In the VLs, contradictory reproducibility
values were observed for the Ki
and vp, for which more patients need to be
investigated.
Furthermore, the
reproducibility of Ki in
the more vascularized GM (more leakage) was lower than in the WM. This might be
caused by stronger partial volume effects in the GM by CSF and macrovessels, which
are likely stronger in the (cortical) GM than WM.
Day-to-day
variation might be induced by variation in the tissue signal and the VIF. Using
session-averaged VIFs, it was observed that the reproducibility of vp improved, whereas Ki did not show this effect.
These results demonstrate
that despite the noisy nature of the measurement, determining subtle leakage in
cerebrovascular patients using dual temporal DCE-MRI is moderately reproducible. Still, cautious interpretation of the Ki and vp in individual patients is needed. Day-to-day
variations may be partly compensated by using session-averaged (or
standardized) VIFs.
Acknowledgements
No acknowledgement found.References
1. Larsson
HBW et al., MRM, 2009;62:1270–81. 2. Taheri S et al., MRM, 2011;65:1036–42 3. Wardlaw
JM et al., Annals of Neurology;
2009;65:194-202 4. Montagne A et al., Neuron; 2015;85:296-302 5. Wong SM et al. Proc. Intl. Soc. Mag. Reson.
Med. 23 (2015):2362 6. Patlak CS et al., J Cereb Blood Flow Metab, 1985;5:584–590. 7. Bland
JM et al., Lancet; 1986;1:307-10.